Elaiophylin reduces body weight and lowers glucose levels in obese mice by activating AMPK

1Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Obesity is an epidemic affecting 13% of the global population and increasing the risk of many chronic diseases. However, only several drugs are licensed for pharmacological intervention for the treatment of obesity. As a master regulator of metabolism, the therapeutic potential of AMPK is widely recognized and aggressively pursued for the treatment of metabolic diseases. We found that elaiophylin (Ela) rapidly activates AMPK in a panel of cancer-cell lines, as well as primary hepatocytes and adipocytes. Meanwhile, Ela inhibits the mTORC1 complex, turning on catabolism and turning off anabolism together with AMPK. In vitro and in vivo studies showed that Ela does not activate AMPK directly, instead, it increases cellular AMP/ATP and ADP/ATP ratios, leading to AMPK phosphorylation in a LKB1-dependent manner. AMPK activation induced by Ela caused changes in diverse metabolic genes, thereby promoting glucose consumption and fatty acid oxidation. Importantly, Ela activates AMPK in mouse liver and adipose tissue. As a consequence, it reduces body weight and blood glucose levels and improves glucose and insulin tolerance in both ob/ob and high-fat diet-induced obese mouse models. Our study has identified a novel AMPK activator as a candidate drug for the treatment of obesity and its associated chronic diseases.

References Powered by Scopus

Prevalence of childhood and adult obesity in the United States, 2011-2012

6706Citations
N/AReaders
Get full text

Obesity

3895Citations
N/AReaders
Get full text

AMPK: A nutrient and energy sensor that maintains energy homeostasis

3521Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Murine Models of Obesity

23Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Bao, R., Meng, Y., Zhang, H., Yang, C., Li, W., Zhang, C., … Dang, Y. (2021). Elaiophylin reduces body weight and lowers glucose levels in obese mice by activating AMPK. Cell Death and Disease, 12(11). https://doi.org/10.1038/s41419-021-04264-9

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

40%

Researcher 2

40%

Professor / Associate Prof. 1

20%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 2

40%

Pharmacology, Toxicology and Pharmaceut... 1

20%

Nursing and Health Professions 1

20%

Medicine and Dentistry 1

20%

Save time finding and organizing research with Mendeley

Sign up for free